0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Interferon and Cancer (Paperback, Softcover reprint of the original 1st ed. 1983) Loot Price: R1,552
Discovery Miles 15 520
Interferon and Cancer (Paperback, Softcover reprint of the original 1st ed. 1983): Karol Sikora

Interferon and Cancer (Paperback, Softcover reprint of the original 1st ed. 1983)

Karol Sikora

 (sign in to rate)
Loot Price R1,552 Discovery Miles 15 520 | Repayment Terms: R145 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Interferon was first discovered in 1957. Over the last five years it has become almost a household word. Many believe it to be a drug with already proven efficacy against cancer and viral infection. The media has distorted any cool scientific view of the data available. We have learned much about the complexity of the interferon system. We know some of the switches involved in interferon gene expression and its secretion by virally and immune stimulated cells. We also know that it binds to a cell surface receptor, mediating its complex effects on target cells by a series of second messengers. The advent of the new techniques of modern molecular biology, such as monoclonal antibodies and gene cloning, has had tremendous impact on the rate of acquisition of knowledge. Such techniques have provided us with almost unlimited quantities of highly purified interferon for clinical trial in patients with a spectrum of infectious and malignant diseases. The information we have gathered raises many more questions. Why should there be several families of interferon genes? What is their true physiolo gical role? How are they interrelated functionally? Interferon is clearly a cellular hormone providing a means of communication between cells. fhether it has clinical value in the management of patients with diseased cells remains to be seen. This book sum marises our current knowledge of interferons as possible an- cancer agents. It is clear interferon is no penicillin for cancer."

General

Imprint: Springer-Verlag New York
Country of origin: United States
Release date: February 2012
First published: 1983
Authors: Karol Sikora
Dimensions: 254 x 178 x 12mm (L x W x T)
Format: Paperback
Pages: 224
Edition: Softcover reprint of the original 1st ed. 1983
ISBN-13: 978-1-4684-1172-0
Categories: Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 1-4684-1172-1
Barcode: 9781468411720

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners